| Pharmaceutical active ingredients: |
| GuaifenesinTerbutaline Sulfate |
| Available forms, composition and doses of Cofbron: |
| N / A |
| Cofbron medical category: |
| Human:Antiasthmatic and COPD preparationsCough and cold preparations |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R03CC53 - Terbutaline, combinationsR05CA03 - Guaifenesin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| MacroPhar |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Cofal-D | Chlorpheniramine Maleate; Dextromethorphan; Phenylpropanolamine Hydrochloride | Alna Biotech |
| Cofamol | Acetaminophen | Cosme Farma Laboratories |
| Cofanol | Ammonium Chloride; Diphenhydramine Hydrochloride; L-Menthol | Nabros Pharma |
| Cofar-D | Chlorpheniramine Maleate; Dextromethorphan; Phenylpropanolamine | Trumac Healthcare |
| Cofasol | Levamisole Hydrochloride | UCI-Farma Industria Farmaceutica |
| Cofdex Capsules | Chlorpheniramine Maleate; Dextromethorphan Hydrobromide; Phenylpropanolamine | Cipla |
| Cofdex CC | Acetaminophen; Dextromethorphan; Diphenhydramine; Phenylephrine; Pseudoephedrine | Cipla |
| Cofdex Forte Expectorant | Bromhexine Hydrochloride; Chlorpheniramine Maleate; Phenylpropanolamine Hydrochloride | Cipla |
| Cofdex Forte Syrup | Chlorpheniramine; Dextromethorphan Hydrobromide; Phenylpropanolamine Hydrochloride | Cipla |
| Cofdex P | Bromhexine Hydrochloride; Dextromethorphan; Menthol; Phenylpropanolamine Hydrochloride | Cipla |